Mark Ellis
Impact in
- Virology top 5%
- Poxvirus research and outbreaks
- HIV Research and Treatment
- Epidemiology top 5%
- Herpesvirus Infections and Treatments
- Cytomegalovirus and herpesvirus research
Papers in
- Epidemiology 29
- Herpesvirus Infections and Treatments 24
- Cytomegalovirus and herpesvirus research 9
- Virology 5
- HIV Research and Treatment 4
- Co-authors
- Colin McLaren (2 shared papers)David W. Barry (8 shared papers)Edgar L. Hill (4 shared papers)Peter M. Collins (1 shared paper)Sandra Nusinoff Lehrman (5 shared papers)David C. Lobe (5 shared papers)Robert C. Hackman (1 shared paper)David H. Shepp (1 shared paper)
- Journals
- Antimicrobial Agents and Chemotherapy (10 papers)Antiviral Research (5 papers)Journal of Antimicrobial Chemotherapy (4 papers)Biotechnology and Bioengineering (3 papers)Poultry Science (2 papers)
- Partner nations
- United StatesUnited KingdomBelgium
In The Last Decade
Mark Ellis
37 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 81
- Virology 159
- Epidemiology 974
- Infectious Diseases 251
- Immunology 240
- Hepatology 53
Countries citing papers authored by Mark Ellis
This map shows the geographic impact of Mark Ellis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Ellis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Ellis more than expected).
Fields of papers citing papers by Mark Ellis
This network shows the impact of papers produced by Mark Ellis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Ellis. The network helps show where Mark Ellis may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Ellis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1983 | 134 | |
| 2 | 1991 | 113 | |
| 3 | 1990 | 94 | |
| 4 | 1987 | 76 | |
| 5 | 1993 | 74 | |
| 6 | 1985 | 58 | |
| 7 | 1987 | 58 | |
| 8 | 1983 | 54 | |
| 9 | 2021 | 50 | |
| 10 | 2013 | 48 | |
| 11 | 1987 | 45 | |
| 12 | 1989 | 44 | |
| 13 | 2016 | 32 | |
| 14 | 1994 | 31 | |
| 15 | 1989 | 30 | |
| 16 | 1981 | 29 | |
| 17 | 1987 | 28 | |
| 18 | Studies on interferon induction and interferon sensitivity of avian reoviruses. | 1984 | 24 |
| 19 | 1986 | 24 | |
| 20 | 1986 | 23 |
About Mark Ellis
Mark Ellis is a scholar working on Epidemiology, Virology, Dermatology, Infectious Diseases and Immunology, having authored 39 papers that have together received 1.3k indexed citations. Recurring topics across this work include Herpesvirus Infections and Treatments (24 papers), Cytomegalovirus and herpesvirus research (9 papers), Toxin Mechanisms and Immunotoxins (6 papers), Monoclonal and Polyclonal Antibodies Research (6 papers), Virus-based gene therapy research (5 papers), Viral gastroenteritis research and epidemiology (4 papers), HIV Research and Treatment (4 papers) and Protein purification and stability (3 papers). The work is most often cited by research in Virology (159 citations), Epidemiology (974 citations), Infectious Diseases (251 citations), Immunology (240 citations) and Hepatology (53 citations). Mark Ellis has collaborated with scholars based in United States, United Kingdom and Belgium. Frequent co-authors include Colin McLaren, David W. Barry, Edgar L. Hill, Peter M. Collins, Sandra Nusinoff Lehrman, David C. Lobe, Robert C. Hackman, David H. Shepp, Caswell S. Eidson and J D Meyers. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Antiviral Research, Journal of Antimicrobial Chemotherapy, Biotechnology and Bioengineering and Poultry Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.